News of Note—McKesson relaunches pharma services


Here is some news of note for the week: 

 > McKesson has relaunched its biopharmaceutical services business. Release

> The EMA says it may seek to order fluoroquinolone and quinolone antibiotics off the market following a review of disabling and potentially long-lasting side effects. Announcement

> Vetter is expanding its secondary packaging operations, adding a second building to its Ravensburg site which will be ready in 2020. Release


Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.